515 related articles for article (PubMed ID: 6308301)
1. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of elderly patients with hepatocellular carcinomas with mitomycin C and 5-fluorouracil].
Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1797-800. PubMed ID: 6307175
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of combination chemotherapy of aclacinomycin A (ACM) and 5-fluorouracil (5-FU) for advanced carcinoma of gastrointestinal tract].
Kikuchi K
Gan To Kagaku Ryoho; 1982 Apr; 9(4):716-21. PubMed ID: 6764110
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer.
De Jager RL; Magill GB; Golbey RB; Krakoff IH
Cancer Treat Rep; 1976 Sep; 60(9):1373-5. PubMed ID: 1016970
[No Abstract] [Full Text] [Related]
5. [Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
Mukai M; Den N; Yamazaki Y; Namiki S; Oda S; Nagao K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):96-102. PubMed ID: 6820880
[TBL] [Abstract][Full Text] [Related]
6. [Experience of a combination chemotherapy consisting of 5-FU, MMC, and FT-207--side effects against kidney].
Yamada F; Kagami H; Fukutome A; Mastumine T; Miura T
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2049-54. PubMed ID: 6412636
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer.
Cocconi G; DeLisi V; Di Blasio B
Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of chemotherapeutic agents in the treatment of primary liver cancer].
Ohya T; Kikuchi S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1623-7. PubMed ID: 6191720
[TBL] [Abstract][Full Text] [Related]
9. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
10. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
[TBL] [Abstract][Full Text] [Related]
11. [Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)].
Kasai Y; Inokuchi K; Hattori T; Inoue K; Taguchi T; Kondo T; Akiyama H; Abe O; Ito I; Nakajima T; Muto T; Kikuchi K; Sugie S; Hayasaka A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1449-60. PubMed ID: 6820917
[TBL] [Abstract][Full Text] [Related]
12. [Single chemotherapy with 5-fluorouracil or ftorafur and combination chemotherapy with mitomycin C and 5-fluorouracil for inoperable elderly gastric cancers].
Fujii M; Murakami N
Nihon Gan Chiryo Gakkai Shi; 1983 Feb; 18(1):1-4. PubMed ID: 6408206
[No Abstract] [Full Text] [Related]
13. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1].
Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Tsuji H; Furusawa M; Tomita M; Taguchi T; Kosaki G; Iwanaga T; Hioki K; Kondo T; Yura J; Hirano M; Miura K; Izuo M; Takemiya S
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2148-60. PubMed ID: 6820891
[TBL] [Abstract][Full Text] [Related]
14. [Randomized study of long-term adjuvant chemotherapy with Futraful and mitomycin C in gastric cancer. A second study (fourth report)].
Taguchi T; Usugane M; Inokuchi K; Hattori T; Inoue K; Kondo T; Akiyama H; Abe O; Nakajima T; Muto T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1833-9. PubMed ID: 3929692
[TBL] [Abstract][Full Text] [Related]
15. [A current overview of chemotherapy in advanced gastric cancer].
Ogawa M
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2161-8. PubMed ID: 2660747
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
[No Abstract] [Full Text] [Related]
17. Clinical management of advanced gastrointestinal cancer.
Moertel CG
Cancer; 1975 Aug; 36(2):675-82. PubMed ID: 168961
[TBL] [Abstract][Full Text] [Related]
18. [Comparison between continuous arterial infusion chemotherapy and mitomycin C microcapsule administration in primary and metastatic liver cancer].
Itoh J; Nakagawa H; Sasaki H; Takahashi T; Katoh T
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1165-9. PubMed ID: 6307162
[TBL] [Abstract][Full Text] [Related]
19. Superselective intra-arterial chemotherapy with mitomycin C in liver and gallbladder cancer.
Kairaluoma MI; Leinonen A; Niemelä R; Kiviniemi H; Siniluoto T; Ståhlberg M
Eur J Surg Oncol; 1988 Feb; 14(1):45-50. PubMed ID: 3126085
[TBL] [Abstract][Full Text] [Related]
20. [Clinical results of CDDP, MMC and 5-FU combination chemotherapy in advanced or recurrent gastrointestinal cancers].
Sakuyama T; Kimura A; Yoshida S; Yanagisawa S; Soji K; Hano H; Takahashi N; Nagao F
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2796-9. PubMed ID: 3115188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
